title: Post-allograft pomalidomide and reversible hepatotoxicity.
authors: Division of Hematology & Oncology, Vanderbilt University, Nashville, TN, USA.
authors: J M
authors: JM
authors: Pauff
authors: Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN, USA.
authors: R S
authors: RS
authors: Gonzalez
authors: Department of Medical Oncology, East Tennessee State University, Johnson City, TN, USA.
authors: K P
authors: KP
authors: Sajnani
authors: Division of Hematology & Oncology, Vanderbilt University, Nashville, TN, USA.
authors: A
authors: A
authors: Kassim
authors: Division of Hematology & Oncology, Vanderbilt University, Nashville, TN, USA.
authors: M
authors: M
authors: Jagasia
mesh_terms: D064591:Allografts; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008099:Liver / Q000473:pathology*; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019172:Transplantation Conditioning / Q000379:methods*
chemical_list: D013792:Thalidomide; C467566:pomalidomide